We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
-2.5%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$333B
AUM Growth
-$5.65B
Cap. Flow
+$10.7B
Cap. Flow %
3.22%
Top 10 Hldgs %
17.75%
Holding
3,695
New
106
Increased
2,783
Reduced
461
Closed
115

Top Buys

Rank Stock Value
1
EOG icon
EOG Resources
EOG
+$727M
2
HD icon
Home Depot
HD
+$472M
3
PFE icon
Pfizer
PFE
+$362M
4
TXN icon
Texas Instruments
TXN
+$314M
5
LYB icon
LyondellBasell Industries
LYB
+$299M

Sector Composition

Rank Sector Weight
1 Technology 21.07%
2 Financials 12.97%
3 Healthcare 12.01%
4 Consumer Discretionary 10.22%
5 Industrials 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GNLN icon
3576
Greenlane Holdings
GNLN
$1.22M
0
TONX
3577
TON Strategy Co
TONX
$168M
$19K ﹤0.01%
2
OPTT icon
3578
Ocean Power Technologies
OPTT
$48.9M
$18K ﹤0.01%
12,445
LABP
3579
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$16K ﹤0.01%
1,035
-361
-26% -$9.18K
AAOI icon
3580
Applied Optoelectronics
AAOI
$7.57B
-10,991
Closed -$57K
ABEO icon
3581
Abeona Therapeutics
ABEO
$366M
-1,411
Closed -$12K
ADIL
3582
Adial Pharmaceuticals
ADIL
$7.31M
-19
Closed -$32K
BIDU icon
3583
Baidu
BIDU
$37.7B
-520,686
Closed -$77.5M
BILI icon
3584
Bilibili
BILI
$7.99B
-329,135
Closed -$15.3M
BOXL icon
3585
Boxlight
BOXL
$2.03M
-13
Closed -$26K
BSV icon
3586
Vanguard Short-Term Bond ETF
BSV
$44.7B
-9,978
Closed -$804K
SRXH
3587
SRX Global
SRXH
$26.9M
-7
Closed -$42K
BYFC icon
3588
Broadway Financial
BYFC
$93.8M
-1,898
Closed -$36K
CATX icon
3589
Perspective Therapeutics
CATX
$332M
-5,547
Closed -$22K
CGNT icon
3590
Cognyte Software
CGNT
$659M
-97,143
Closed -$1.52M
CRBP icon
3591
Corbus Pharmaceuticals
CRBP
$166M
-1,499
Closed -$28K
CRVS icon
3592
Corvus Pharmaceuticals
CRVS
$1.12B
-11,217
Closed -$28K
CVAC
3593
DELISTED
CureVac
CVAC
-6,244
Closed -$215K
CYCN icon
3594
Cyclerion Therapeutics
CYCN
$14.9M
-775
Closed -$27K
DOMH icon
3595
Dominari Holdings
DOMH
$57.4M
-2,208
Closed -$23K
EEM icon
3596
iShares MSCI Emerging Markets ETF
EEM
$28.8B
-20,086
Closed -$981K
GDS icon
3597
GDS Holdings
GDS
$6.56B
-151,410
Closed -$7.14M
CBIO
3598
Crescent Biopharma
CBIO
$537M
-349
Closed -$51K
GOCO
3599
DELISTED
GoHealth
GOCO
-2,412
Closed -$138K
GOTU icon
3600
Gaotu Techedu
GOTU
$434M
-192,808
Closed -$375K

Similar funds

Charles Schwab's Q1 2022 Portfolio in Review

As of Q1 2022, Charles Schwab held 3,695 positions worth $333B, down 1.7% from $339B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Charles Schwab deployed $10.7B of net new capital in Q1 2022, opening 106 new positions and adding to 2,783 existing holdings. Its largest new stake was Constellation Energy: 1,449,939 shares worth $81.6M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Emerson Electric, an estimated $567M trimmed.

  • Charles Schwab's largest Q1 2022 buy was Constellation Energy: 1,449,939 shares worth $81.6M.
  • Charles Schwab added most to EOG Resources in Q1 2022, an estimated $727M increase.
  • Charles Schwab's biggest Q1 2022 reduction was Emerson Electric, cutting an estimated $567M.
  • Charles Schwab fully exited Xilinx Inc in Q1 2022, selling an estimated $245M.
  • Charles Schwab's ten largest holdings make up 18% of its $333B portfolio in Q1 2022.
  • Charles Schwab opened 106 new positions and closed 115 in Q1 2022.
  • Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $333B.

Based on Charles Schwab's 13F filing for Q1 2022, filed 13 May 2022.